PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE)...

Value in Health 2018 / 10 Vol. 21

PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

Hiligsmann, M., Reginster, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1777
Date:
October, 2018
File:
PDF, 379 KB
2018
Conversion to is in progress
Conversion to is failed